TLR4 and cancer: However, the scope of cancer treatment relying solely on the LPS-TLR4 pathway is limited, as evidenced by the inhibitory effect of purified LPS against CT26 tumors being comparable to live bacteria-mediated immunotherapy but less effective against other tumors [162].